Analysis of Percutaneous Ablations for Cancer Treatment

Completed

• Conditions: Cancer

• Registration Number: NCT01563679
• Lead Sponsor: Emory University

Brief Summary

This is a study involving patients with cancer who are referred by their treating physician for percutaneous locoregional therapies.

Patient's clinical and radiology findings, pathology findings, survival, treatment responses, and complications after their locoregional therapy will be studied.

Detailed Description

The efficacy of the percutaneous and transarterial treatments for solid tumors will be studied. Prospective study on patients who receive percutaneous locoregional therapies, including radiofrequency ablation (RFA), cryoablation, microwave ablation, IRE and chemical ablation for treatment of cancer will be performed.

Preoperative clinic chart, procedure note, postoperative chart, pre- and post-operative CT, MRI or Ultrasound, angiographic findings, biopsy results and pathologic findings, will be reviewed. Patient survival, treatment responses, complications after the therapy will be collected from clinic visits and clinical encounters.

Patient overall performance status before and after procedures will be assessed using the Quality of Life questionnaire (SF-36™ Health Survey).

Basic Information
|
Recruitment & Eligibility
|
Study & Design
|
Trial Locations

Study Timeline

• Study Start: 2012-02
• Study First Submitted: 2012-03-12
• Study First Submitted QC: 2012-03-23
• Study First Posted: 2012-03-27
• Primary Completion: 2014-01
• Study Completion: 2014-01
• Status Verified: 2014-05
• Last Update Submitted: 2014-05-23
• Last Update Posted: 2014-05-28

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 26

Inclusion Criteria

• 18yrs of age
• Cancer diagnosis
• Candidate for Locoregional therapy
• Willingness to sign informed consent

Read More

Exclusion Criteria

• Unable to sign informed consent
• Patients not eligible for locoregional therapies

Read More

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Effect of percutaneous and transarterial treatments for cancer in quality of life	1 year	Patients will complete the QOL questionnare during their follow up visits after procedure. 1 month, 3 months, 6 months and 1 year.

Secondary Outcome Measures

Name	Time	Method
response rate to percutaneous and transarterial treatment for cancer	1 month, 3 months, 6 months, 1 year.	Patients will be followed up 1, 3, 6 and 1year intervals after procedure.

Trial Locations

Locations (1)

Emory University Hospital; 🇺🇸 Altanta, Georgia, United States